ADB-HEXINACA

ADB-HEXINACA is a synthetic cannabinoid that has been identified in herbal blends. Its name refers to its structure, which has a 1-amino-3,3-dimethyl-1-oxobutan-2-yl group replaced by a hexyl chain. ADB-HEXINACA was first identified in Japan in 2013.

Chemistry

ADB-HEXINACA is a synthetic cannabinoid that features a hexyl chain substituted on the terminal carbon of the pentyl group. It has been reported to have a Ki value of 0.36nM at CB1 and 0.69nM at CB2.

Pharmacology

ADB-HEXINACA acts as a full agonist with a binding affinity of 1.2 nM at CB1 and 1.1 nM at CB2 cannabinoid receptors.

Legality

ADB-HEXINACA is a controlled substance in some countries including Japan and Latvia. In the United States, ADB-HEXINACA is a Schedule I controlled substance.

See also

• Synthetic cannabinoids
• Cannabinoid receptor
• Controlled Substances Act

References

ADB-HEXINACA Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski